Form 4: National Healthcare Corp Director Emil Hassan Reports Option Grant

Director Emil Hassan reports the grant of stock options in National Healthcare Corp.

Summary

• Emil Hassan, a director of National Healthcare Corp, filed a Form 4 on May 8, 2025, reporting a transaction.
• The transaction involves the grant of stock options to purchase 7,500 shares of common stock.
• These options were granted on May 8, 2025, under the 2020 Omnibus Equity Incentive Plan.
• The exercise price of the options is $94.66.
• The options become exercisable on May 8, 2026, and expire on May 7, 2030.
• Following the transaction, Hassan directly owns 78,595 shares of common stock and holds options to purchase an additional 30,000 shares.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of an option grant, which is neither particularly positive nor negative. It's a standard part of executive compensation.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The director's existing holdings of 78,595 shares demonstrate a significant investment in the company.

Industry Context

Stock option grants are a common form of executive compensation in the healthcare industry, aligning management's interests with shareholder value.

Stakeholder Impact

• The option grant could incentivize the director to improve company performance, benefiting shareholders.
• The dilution effect of potential option exercises is minimal given the relatively small number of shares involved.

Key Dates

Keywords

stock options, Form 4, director, NHC, National Healthcare Corp, insider trading